SE0003828D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0003828D0 SE0003828D0 SE0003828A SE0003828A SE0003828D0 SE 0003828 D0 SE0003828 D0 SE 0003828D0 SE 0003828 A SE0003828 A SE 0003828A SE 0003828 A SE0003828 A SE 0003828A SE 0003828 D0 SE0003828 D0 SE 0003828D0
- Authority
- SE
- Sweden
- Prior art keywords
- diseases
- psoriasis
- compounds
- skin
- arthritis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0003828A SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Novel compounds |
JP2002535743A JP4250416B2 (ja) | 2000-10-20 | 2001-10-16 | ケモカイン関連疾患の処置のための7−アミノ−2−アルキルチオプテリジン−4−イルアミン |
PCT/SE2001/002265 WO2002032507A1 (en) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
DE60125801T DE60125801T2 (de) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amine zur behandlung von chemokinassoziierten erkrankungen |
AT01977001T ATE350102T1 (de) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amine zur behandlung von chemokinassoziierten erkrankungen |
AU2001296151A AU2001296151A1 (en) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
US10/399,570 US7071193B2 (en) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
ES01977001T ES2276836T3 (es) | 2000-10-20 | 2001-10-16 | 7-amino-2-alquiltiopteridin-4-il-aminas para el tratamiento de enfermedades relacionadas con las quimioquinas. |
EP01977001A EP1328319B1 (en) | 2000-10-20 | 2001-10-16 | 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0003828A SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0003828D0 true SE0003828D0 (sv) | 2000-10-20 |
Family
ID=20281519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0003828A SE0003828D0 (sv) | 2000-10-20 | 2000-10-20 | Novel compounds |
Country Status (9)
Country | Link |
---|---|
US (1) | US7071193B2 (sv) |
EP (1) | EP1328319B1 (sv) |
JP (1) | JP4250416B2 (sv) |
AT (1) | ATE350102T1 (sv) |
AU (1) | AU2001296151A1 (sv) |
DE (1) | DE60125801T2 (sv) |
ES (1) | ES2276836T3 (sv) |
SE (1) | SE0003828D0 (sv) |
WO (1) | WO2002032507A1 (sv) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2413324A (en) * | 2004-04-22 | 2005-10-26 | 4 Aza Bioscience Nv | Pharmaceutically active pteridine derivatives |
US7276506B2 (en) * | 1998-12-28 | 2007-10-02 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
US6946465B2 (en) * | 1999-02-02 | 2005-09-20 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
SE9903544D0 (sv) * | 1999-10-01 | 1999-10-01 | Astra Pharma Prod | Novel compounds |
GB2359551A (en) * | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
SE0102716D0 (sv) * | 2001-08-14 | 2001-08-14 | Astrazeneca Ab | Novel compounds |
GB0221829D0 (en) * | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
GB0221828D0 (en) * | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
DE602004009696T2 (de) * | 2003-08-29 | 2008-08-28 | 4 Aza Ip Nv | Immunosuppressive wirkungen von pteridinderivativen |
EP1663244B1 (en) * | 2003-09-12 | 2007-08-15 | 4 Aza Ip Nv | Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
US20070032477A1 (en) * | 2003-10-17 | 2007-02-08 | Waer Mark J A | Pteridine derivatives useful for making pharmaceutical compositions |
PL1673092T3 (pl) * | 2003-10-17 | 2008-01-31 | 4 Aza Ip Nv | Pochodne pterydyny podstawione heterocyklem i ich zastosowanie w leczeniu |
GB0328243D0 (en) * | 2003-12-05 | 2004-01-07 | Astrazeneca Ab | Methods |
WO2008009079A2 (en) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
US20170275287A1 (en) * | 2014-08-22 | 2017-09-28 | Janus Biotherapeutics, Inc. | Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof |
CU20170115A7 (es) | 2015-03-04 | 2018-03-13 | Gilead Sciences Inc | Compuestos moduladores de receptor de tipo toll |
ES2826748T3 (es) | 2016-09-02 | 2021-05-19 | Gilead Sciences Inc | Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll |
CN109923106B (zh) | 2016-09-02 | 2022-09-13 | 吉利德科学公司 | toll样受体调节剂化合物 |
TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2924472A (en) | 1957-06-27 | 1960-02-09 | Gen Motors Corp | Pipe joint seal |
GB1009477A (en) * | 1962-02-13 | 1965-11-10 | Smith Kline French Lab | Novel process for preparing heterocyclic compounds |
US3182062A (en) * | 1962-02-28 | 1965-05-04 | Smith Kline French Lab | Synthesis of quinoxalines and analogues thereof |
US3318900A (en) | 1964-05-06 | 1967-05-09 | Janssen Pharmaceutica Nv | Derivatives of benzimidazolinyl piperidine |
BE668603A (sv) | 1964-08-20 | |||
DE2331223C2 (de) | 1972-06-19 | 1984-11-22 | Kohjin Co., Ltd., Tokio / Tokyo | S-substituierte-2-Thioadenosine, deren 5'-Monophosphate, Verfahren zu deren Herstellung und Arzneimittel, welche diese enthalten |
JPS5188994A (en) | 1975-02-04 | 1976-08-04 | Shinkijichikan 88 aminoadeninjudotainoseizoho | |
US4120521A (en) | 1975-08-28 | 1978-10-17 | Rieber & Son Plastic-Industri A/S | Combined mould element and sealing ring |
EG12406A (en) | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
GB1600293A (en) | 1977-02-04 | 1981-10-14 | British Oceanics Ltd | Sealing arrangements |
US4188040A (en) | 1977-04-06 | 1980-02-12 | Firma WOCO Franz-Josef Wolf & Co. | Sealing ring |
DE2726959A1 (de) | 1977-06-15 | 1979-01-18 | Arlt Christian | Dichteinsatz zum dichten verbinden von zwei rohren |
FR2421899A1 (fr) | 1978-01-16 | 1979-11-02 | Roussel Uclaf | Nouveaux derives du tetrahydropyridinyl-indole et leurs sels, le procede de preparation et l'application a titre de medicaments de ces nouveaux produits |
US4410528A (en) | 1980-05-16 | 1983-10-18 | Kyowa Hakko Kogyo Co., Ltd. | Hypotensive piperidine derivatives |
DE3219522A1 (de) | 1981-10-28 | 1983-12-01 | Denso-Chemie Wedekind Kg, 5090 Leverkusen | Steckmuffendichtung fuer rohre |
FR2547888B1 (fr) | 1983-06-22 | 1985-12-13 | Sabla Sa | Bague d'etancheite a implants pour tuyaux a emboitement |
CA1338012C (en) | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
SE8800348L (sv) | 1988-02-03 | 1989-08-04 | Forsheda Ab | Taetningsring och verktyg foer framstaellning daerav |
FR2659656B1 (fr) | 1990-03-15 | 1994-09-09 | Sanofi Sa | Derives de pyrimidinedione-2,4 et medicaments les contenant. |
DE4119767A1 (de) | 1991-06-15 | 1992-12-17 | Dresden Arzneimittel | Verfahren zur herstellung von (pyrimid-2-yl-thio- bzw. seleno)-essigsaeurederivaten |
US5169161A (en) | 1991-09-19 | 1992-12-08 | Hail Mary Rubber Co., Inc. | Symmetrical gasket for pipe joints |
DE4134089C2 (de) | 1991-10-15 | 1994-10-13 | Dueker Eisenwerk | Schubgesicherte Muffenverbindung |
DE4229609C2 (de) | 1992-09-04 | 2003-05-08 | Forsheda Stefa Gmbh | Abdichtung zwischen zwei ineinandersteckbaren Teilen |
US5521197A (en) | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
DE69628804T2 (de) | 1995-12-08 | 2003-12-18 | Pfizer | Substitutierte heterozyclische Derivate als CRF Antagonisten |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
SE515033C2 (sv) | 1995-12-27 | 2001-06-05 | Forsheda Ab | Tätningsanordning |
US6184225B1 (en) | 1996-02-13 | 2001-02-06 | Zeneca Limited | Quinazoline derivatives as VEGF inhibitors |
DE69709319T2 (de) | 1996-03-05 | 2002-08-14 | Astrazeneca Ab | 4-anilinochinazolin derivate |
ATE341542T1 (de) | 1996-04-19 | 2006-10-15 | Neurosearch As | 1-(4-piperidyl)-benzimidazole mit neurotropher aktivität |
SK23399A3 (en) | 1996-08-28 | 2000-08-14 | Pfizer | 6,5-hetero-bicyclic derivatives, use thereof and pharmaceutical composition on their base |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
CN1064533C (zh) * | 1996-10-24 | 2001-04-18 | 沈春楼 | 一种治疗由风寒湿痹引起的红肿热痛复方胶囊 |
AU5522498A (en) | 1996-12-13 | 1998-07-03 | Merck & Co., Inc. | Substituted aryl piperazines as modulators of chemokine receptor activity |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
EP1003514A4 (en) | 1997-07-25 | 2000-10-11 | Merck & Co Inc | CYCLIC AMINE MODULATORS OF CHEMOKIN RECEPTORS |
AR013669A1 (es) | 1997-10-07 | 2001-01-10 | Smithkline Beecham Corp | Compuestos y metodos |
DE69817393T2 (de) | 1997-11-28 | 2004-06-17 | Sumitomo Pharmaceuticals Co., Ltd. | Neue heterozyklische verbindungen |
US6423725B1 (en) | 1998-01-19 | 2002-07-23 | Pfizer Inc | 4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists |
CN1166665C (zh) | 1998-03-19 | 2004-09-15 | 日本农药株式会社 | 芳基哌啶衍生物及其用途 |
CA2326884A1 (en) | 1998-04-03 | 1999-10-14 | Dupont Pharmaceuticals Company | Thiazolo¬4,5-d|pyrimidines and pyridines as corticotropin releasing factor (crf) antagonists |
MA26659A1 (fr) | 1998-08-06 | 2004-12-20 | Pfizer | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. |
SE9802729D0 (sv) | 1998-08-13 | 1998-08-13 | Astra Pharma Prod | Novel Compounds |
US5988695A (en) | 1998-08-26 | 1999-11-23 | S&B Technical Products, Inc. | Pipe gasket with embedded ring |
PE20001420A1 (es) | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
ATE277929T1 (de) | 1998-12-28 | 2004-10-15 | 4 Aza Bioscience Nv | Immunsuppressive wirkungen von pteridinderivaten |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
EP1187615A2 (en) | 1999-02-02 | 2002-03-20 | K.U. Leuven Research & Development | Immunosurpressive effects of pteridine derivatives |
US6248755B1 (en) | 1999-04-06 | 2001-06-19 | Merck & Co., Inc. | Pyrrolidine modulators of chemokine receptor activity |
US6142484A (en) | 1999-04-15 | 2000-11-07 | Vassallo Research & Development Corporation | Composite multi-pressure gasket |
WO2000076514A1 (en) | 1999-06-11 | 2000-12-21 | Merck & Co., Inc. | Cyclopentyl modulators of chemokine receptor activity |
US6340681B1 (en) | 1999-07-16 | 2002-01-22 | Pfizer Inc | 2-benzimidazolylamine compounds as ORL-1-receptor agonists |
US7169778B2 (en) | 1999-09-15 | 2007-01-30 | Warner-Lambert Company | Pteridinones as kinase inhibitors |
SE9903544D0 (sv) | 1999-10-01 | 1999-10-01 | Astra Pharma Prod | Novel compounds |
AR025884A1 (es) | 1999-10-01 | 2002-12-18 | Takeda Pharmaceutical | Compuestos de amina ciclica, su produccion y su uso |
ATE306488T1 (de) | 2000-01-05 | 2005-10-15 | Pfizer | Benzimidazol-verbindungen zur verwendung als orl1-rezeptor-antagonisten |
GB2359081A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active thiazolopyrimidines |
GB2359079A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
GB2359078A (en) | 2000-02-11 | 2001-08-15 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
EP1257555B1 (en) | 2000-02-11 | 2003-12-03 | AstraZeneca AB | Pyrimidine compounds and their use as modulators of chemokine receptor activity |
GB2359551A (en) | 2000-02-23 | 2001-08-29 | Astrazeneca Uk Ltd | Pharmaceutically active pyrimidine derivatives |
US6790854B2 (en) | 2000-03-24 | 2004-09-14 | Meiji Seika Kaisha, Ltd. | Diphenylalkylamine derivatives useful as opioid receptor agonists |
JP2003535078A (ja) | 2000-05-31 | 2003-11-25 | アストラゼネカ アクチボラグ | 血管損傷活性のあるインドール誘導体 |
BR0112224A (pt) | 2000-07-07 | 2003-06-10 | Angiogene Pharm Ltd | Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto |
EP1301498A1 (en) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
SE0101322D0 (sv) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | Novel compounds |
SE0102716D0 (sv) | 2001-08-14 | 2001-08-14 | Astrazeneca Ab | Novel compounds |
GB0221828D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
GB0221829D0 (en) | 2002-09-20 | 2002-10-30 | Astrazeneca Ab | Novel compound |
-
2000
- 2000-10-20 SE SE0003828A patent/SE0003828D0/sv unknown
-
2001
- 2001-10-16 AU AU2001296151A patent/AU2001296151A1/en not_active Abandoned
- 2001-10-16 ES ES01977001T patent/ES2276836T3/es not_active Expired - Lifetime
- 2001-10-16 AT AT01977001T patent/ATE350102T1/de not_active IP Right Cessation
- 2001-10-16 EP EP01977001A patent/EP1328319B1/en not_active Expired - Lifetime
- 2001-10-16 US US10/399,570 patent/US7071193B2/en not_active Expired - Fee Related
- 2001-10-16 JP JP2002535743A patent/JP4250416B2/ja not_active Expired - Fee Related
- 2001-10-16 DE DE60125801T patent/DE60125801T2/de not_active Expired - Fee Related
- 2001-10-16 WO PCT/SE2001/002265 patent/WO2002032507A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US7071193B2 (en) | 2006-07-04 |
WO2002032507A1 (en) | 2002-04-25 |
DE60125801T2 (de) | 2007-10-11 |
AU2001296151A1 (en) | 2002-04-29 |
JP4250416B2 (ja) | 2009-04-08 |
ES2276836T3 (es) | 2007-07-01 |
US20040102447A1 (en) | 2004-05-27 |
ATE350102T1 (de) | 2007-01-15 |
EP1328319A1 (en) | 2003-07-23 |
EP1328319B1 (en) | 2007-01-03 |
JP2004511532A (ja) | 2004-04-15 |
DE60125801D1 (de) | 2007-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0003828D0 (sv) | Novel compounds | |
HUP0400718A2 (hu) | PDE7 és PDE4 kettős inhibitorok alkalmazása leukocita aktivitással társult betegségek kezelésére szolgáló gyógyszerkészítmények előállítására | |
US5925772A (en) | Cysteine protease inhibitors containing heterocyclic leaving groups | |
JP2005529890A5 (sv) | ||
JP2005531584A5 (sv) | ||
ATE330585T2 (de) | Behandlung von atemerkrankungen | |
EP1005485A4 (en) | NOVEL PULMONARY SURFACTANTS AND THERAPEUTIC USES, INCLUDING PULMONARY WASHING | |
BR9808998A (pt) | Imidazóis substituìdos úteis no tratamento de doenças inflamatórias | |
SE0102300D0 (sv) | Compounds | |
NO20000573D0 (no) | Kjemiske forbindelser | |
TW200504069A (en) | Novel fused heteroaromatic compounds as transforming growth factor (TGF) inhibitors | |
EP1348709A3 (en) | Thiazolo (4,5-D) pyrimidine compounds | |
HRP20100359T1 (hr) | Specifični glukokortikoidni spoj s protuupalnom aktivnošću | |
ATE479433T1 (de) | Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel | |
IL161867A (en) | History of 8-pyrazole-xanthine, a process for making them and pharmaceutical preparations containing them | |
BRPI0409109A (pt) | novos compostos | |
MXPA04002379A (es) | Compuestos novedosos. | |
EP0403158A3 (en) | Imidazolyl-alkenoic acids | |
DE3688038D1 (de) | Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst. | |
WO2002065979A3 (en) | (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes | |
IT1226727B (it) | Farmaci precursori della dopamina. | |
BR0109294A (pt) | ster polissacarìdico, composições farmacêuticas, uso do éster polissacarìdico, e, processo para a preparação dos ésteres polissacarìdicos | |
EP0173664A3 (en) | Biologically active benzimidazole compounds and process for their preparation | |
WO2002096467A3 (en) | Pharmaceutical use for secreted bacterial effector proteins | |
ITRM20000340A0 (it) | Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara |